DAILYZ HEALTH NEWS

March 07, 2024 1 min read Add topic to email alerts Receive an email when new articles are posted on

March 8, 2024 Evan Vega

Are Fortified Children’s Breakfast Cereals Just Candy?

The industry responds to the charge that breakfast cereals are too sugary. In 1941, the American Medical Association’s Council on

Infectious Disease

March 7, 2024 Evan Vega

Early air pollution exposure may heighten childhood asthma risk

March 07, 2024 4 min read Add topic to email alerts Receive an email when new articles are posted on

Public Health

March 7, 2024 Evan Vega

Operating in the Red: Half of Rural Hospitals Lose Money, as Many Cut Services

In a little more than two years as CEO of a small hospital in Wyoming, Dave Ryerse has witnessed firsthand

Public Health

March 7, 2024 Evan Vega

When It Comes to Ketamine, Meta’s Posting Policy Is No Party to Decipher

People keep talking about ketamine. The drug has become a favorite of celebrities, billionaires, and ordinary patients, many of whom

Medicare should negotiate prices for 50 drugs each year

Public Health

March 7, 2024 Evan Vega

Medicare should negotiate prices for 50 drugs each year

President Joe Biden speaks during an event at the National Institutes of Health in Bethesda, Maryland, Dec. 14, 2023. Chris

Infectious Disease

March 7, 2024 Evan Vega

Injectable ART given every 8 weeks safely suppresses HIV in adolescents

March 06, 2024 2 min read Add topic to email alerts Receive an email when new articles are posted on

Infectious Disease

March 6, 2024 Evan Vega

Having access to long-acting option increased PrEP coverage in Ugandan study

March 06, 2024 2 min read Add topic to email alerts Receive an email when new articles are posted on

Neurological

March 6, 2024 Evan Vega

FDA Approves Single-Dose, Self-Controlled Delivery Device for Acthar Gel

The Food and Drug Administration (FDA) has approved a new single-dose prefilled SelfJect Injector of Acthar® Gel (repository corticotropin injection).

Dexcom Stelo over-the-counter glucose monitor cleared by the FDA

Public Health

March 6, 2024 Evan Vega

Dexcom Stelo over-the-counter glucose monitor cleared by the FDA

The Dexcom logo is seen on a smartphone screen and in the background. Pavlo Gonchar | SOPA Images | Lightrocket

DAILYZ HEALTH NEWS

DAILYZ HEALTH NEWS

WHO Issues Global Health Emergency Over Rapidly Spreading Drug-Resistant Tuberculosis Strain as Cases Detected in U.S. Travelers

Biden administration unveils new plan to cap insulin out-of-pocket costs at $35 for all insured Americans, expanding earlier Medicare-only protections

FDA Approves First Gene-Editing Therapy for Type 1 Diabetes, Marking Major Milestone in Cell-Based Treatment

Randomized trial in NEJM shows hybrid closed‑loop insulin pump improves A1c and reduces severe hypoglycemia in type 1 diabetes

FDA approves first oral small‑molecule treatment RebiQuent for moderate to severe atopic dermatitis in adults

WHO Issues Global Health Emergency Over Rapidly Spreading Drug-Resistant Tuberculosis Strain as Cases Detected in U.S. Travelers

Biden administration unveils new plan to cap insulin out-of-pocket costs at $35 for all insured Americans, expanding earlier Medicare-only protections

FDA Approves First Gene-Editing Therapy for Type 1 Diabetes, Marking Major Milestone in Cell-Based Treatment

Randomized trial in NEJM shows hybrid closed‑loop insulin pump improves A1c and reduces severe hypoglycemia in type 1 diabetes

WHO Issues Global Health Emergency Over Rapidly Spreading Drug-Resistant Tuberculosis Strain as Cases Detected in U.S. Travelers

Biden administration unveils new plan to cap insulin out-of-pocket costs at $35 for all insured Americans, expanding earlier Medicare-only protections

FDA Approves First Gene-Editing Therapy for Type 1 Diabetes, Marking Major Milestone in Cell-Based Treatment

Randomized trial in NEJM shows hybrid closed‑loop insulin pump improves A1c and reduces severe hypoglycemia in type 1 diabetes

FDA approves first oral small‑molecule treatment RebiQuent for moderate to severe atopic dermatitis in adults

WHO Issues Global Health Emergency Over Rapidly Spreading Drug-Resistant Tuberculosis Strain as Cases Detected in U.S. Travelers

Biden administration unveils new plan to cap insulin out-of-pocket costs at $35 for all insured Americans, expanding earlier Medicare-only protections

FDA Approves First Gene-Editing Therapy for Type 1 Diabetes, Marking Major Milestone in Cell-Based Treatment

Randomized trial in NEJM shows hybrid closed‑loop insulin pump improves A1c and reduces severe hypoglycemia in type 1 diabetes

WHO Issues Global Health Emergency Over Rapidly Spreading Drug-Resistant Tuberculosis Strain as Cases Detected in U.S. Travelers

Biden administration unveils new plan to cap insulin out-of-pocket costs at $35 for all insured Americans, expanding earlier Medicare-only protections

FDA Approves First Gene-Editing Therapy for Type 1 Diabetes, Marking Major Milestone in Cell-Based Treatment

Randomized trial in NEJM shows hybrid closed‑loop insulin pump improves A1c and reduces severe hypoglycemia in type 1 diabetes

FDA approves first oral small‑molecule treatment RebiQuent for moderate to severe atopic dermatitis in adults

Nirsevimab highly effective at preventing RSV hospitalization in infants, report shows

Are Fortified Children’s Breakfast Cereals Just Candy?

Early air pollution exposure may heighten childhood asthma risk

Operating in the Red: Half of Rural Hospitals Lose Money, as Many Cut Services

When It Comes to Ketamine, Meta’s Posting Policy Is No Party to Decipher

Medicare should negotiate prices for 50 drugs each year

Injectable ART given every 8 weeks safely suppresses HIV in adolescents

Having access to long-acting option increased PrEP coverage in Ugandan study

FDA Approves Single-Dose, Self-Controlled Delivery Device for Acthar Gel

Dexcom Stelo over-the-counter glucose monitor cleared by the FDA